NCT04383665

Brief Summary

Rationale: Parkinson's disease patients with deep brain stimulation electrodes represent a unique opportunity to study the influence of basal ganglia on neurocognitive function. Intervention: Patients' deep brain stimulators will be turned off or on and the frequency will be changed to either theta or gamma. Objectives: To identify differences in higher cognitive functions with stimulation "on" and "off" and theta versus gamma frequency stimulation. Study population: 12 patients who had previously undergone bilateral STN deep brain stimulation implantation. Study methodology: Patients will undergo four sessions of neuropsychological testing (RNGT, verbal fluency, D-KEFS CWIT) at baseline, no stimulation, theta stimulation and gamma stimulation, in random order over one day. Study outcomes: Test results of RNGT, verbal fluency, D-KEFS CWIT. Follow-up: none Statistics: Test results will be analyzed using within-subjects statistical tests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 7, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 15, 2021

Completed
Last Updated

July 15, 2021

Status Verified

June 1, 2021

Enrollment Period

1 month

First QC Date

May 7, 2020

Results QC Date

May 6, 2021

Last Update Submit

June 24, 2021

Conditions

Keywords

CognitionHippocampusLanguageMemoryNeuromodulationRandomized controlled trial

Outcome Measures

Primary Outcomes (3)

  • Delis-Kaplan Executive Function System Verbal Fluency

    Number of words per category in one minute

    5-15 minutes following stimulation frequency setting change.

  • Delis-Kaplan Executive Function System Color Word Interference Task

    Time to completion of a color-word interference task

    5-15 minutes following stimulation frequency setting change.

  • Random Number Generation

    Listing of 100 numbers at 1 Hz in a random order. Evan's RNG: a measure of disproportion with which one number follows another in a sequence. Scores range from 0 (equal proportion of sequence pairs) to 1 (maximum disproportion of sequence pairs). A higher score indicates a lower randomness and poorer exective function. Count score 1: a measure of propensity to count in steps of 1. The length of each sequence with steps of 1 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 1) to 100000 (all sequences with steps of 1). A higher score indicates lower randomness and poorer exective function. Count score 2: a measure of propensity to count in steps of 2. The length of each sequence with steps of 2 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 2) to 100000 (all sequences with steps of 2). A higher score indicates lower randomness and poorer exective function. Evan's RNG, count score 1 and cou

    5-15 minutes following stimulation frequency setting change.

Study Arms (3)

STN DBS off

SHAM COMPARATOR
Device: STN DBS off

STN DBS 10Hz

EXPERIMENTAL
Device: STN DBS 10Hz

STN DBS 130Hz

ACTIVE COMPARATOR
Device: STN DBS 130Hz

Interventions

Stimulation of existing DBS device at 100Hz, with other parameters at baseline

STN DBS 10Hz

Stimulation of existing DBS device at 130Hz, with other parameters at baseline

STN DBS 130Hz

Existing DBS device turned off

STN DBS off

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients who had previously undergone bilateral STN deep brain stimulation implantation
  • Age \>18 years old
  • Stable medication regimen for at least 3 months.
  • Patient informed and able to give written consent
  • Able to comply with all testing, follow-ups and study appointments and protocols

You may not qualify if:

  • History of epilepsy or seizure
  • History of major substance abuse
  • Patients with baseline settings at less than 1.5 V will be excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keck hospital of the University of Southern California

Los Angeles, California, 90033, United States

Location

Related Publications (3)

  • Evans FJ. Monitoring attention deployment by random number generation: An index to measure subjective randomness. Bull Psychon Soc 1978;12:35-8.

    BACKGROUND
  • Spatt J, Goldenberg G. Components of random generation by normal subjects and patients with dysexecutive syndrome. Brain Cogn. 1993 Nov;23(2):231-42. doi: 10.1006/brcg.1993.1057.

    PMID: 8292327BACKGROUND
  • Towse JN, Neil D. Analyzing human random generation behavior: A review of methods used and a computer program for describing performance. Behav Res Methods Instrum Comput 1998;30:583-91.

    BACKGROUND

Related Links

MeSH Terms

Conditions

Parkinson DiseaseLanguage

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesCommunicationBehavior

Limitations and Caveats

Our study did not control for motor state during testing. Our sample population was not fully representative of the worldwide population of patients with PD. Our study was not designed nor powered to investigate inter-subject differences such as age, time from DBS implantation, education, first language, or motor function. Unknown is the adequacy of a 5-min period of stimulation prior to each round of neuropsychological testing.

Results Point of Contact

Title
Dr Darrin Lee
Organization
Keck School of Medicine of University of Southern California

Study Officials

  • Darrin J Lee, MD PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Neurosurgery

Study Record Dates

First Submitted

May 7, 2020

First Posted

May 12, 2020

Study Start

January 31, 2020

Primary Completion

March 3, 2020

Study Completion

March 3, 2020

Last Updated

July 15, 2021

Results First Posted

July 15, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations